Yasushi Isobe

2.6k total citations
56 papers, 1.6k citations indexed

About

Yasushi Isobe is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Yasushi Isobe has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 28 papers in Oncology and 22 papers in Immunology. Recurrent topics in Yasushi Isobe's work include Lymphoma Diagnosis and Treatment (32 papers), Viral-associated cancers and disorders (20 papers) and Immune Cell Function and Interaction (16 papers). Yasushi Isobe is often cited by papers focused on Lymphoma Diagnosis and Treatment (32 papers), Viral-associated cancers and disorders (20 papers) and Immune Cell Function and Interaction (16 papers). Yasushi Isobe collaborates with scholars based in Japan, United States and South Korea. Yasushi Isobe's co-authors include Kazuo Oshimi, Motoko Yamaguchi, Shigeo Nakamura, Junji Suzumiya, Ritsuro Suzuki, Koichi Sugimoto, Koji Izutsu, Rie Hyo, Fumihiro Ishida and Hiroshi Kimura and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Yasushi Isobe

52 papers receiving 1.6k citations

Peers

Countries citing papers authored by Yasushi Isobe

Since Specialization

Citations

This map shows the geographic impact of Yasushi Isobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Isobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Isobe more than expected).

Fields of papers citing papers by Yasushi Isobe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasushi Isobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Isobe. The network helps show where Yasushi Isobe may publish in the future.

Co-authorship network of co-authors of Yasushi Isobe

This figure shows the co-authorship network connecting the top 25 collaborators of Yasushi Isobe. A scholar is included among the top collaborators of Yasushi Isobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasushi Isobe. Yasushi Isobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele 2019 ·International Journal of Hematology ·Yuji Nishio, (unknown), (unknown), Akiko Uchida, (unknown), Manabu Matsunawa, Yasushi Isobe, Masayuki Kato, Naoto Tomita, Ikuo Miura	2
2	Targeting BCL2 with venetoclax is a promising therapeutic strategy for “double-proteinexpression” lymphoma with MYC and BCL2 rearrangements 2018 ·Haematologica ·Akiko Uchida, Yasushi Isobe, (unknown), (unknown), Masahiro Hoshikawa, Masayuki Takagi, Ikuo Miura	15
3	An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome 2017 ·Leukemia Research ·(unknown), Ken‐Ichi Imadome, Shinobu Tamura, (unknown), Shogo Murata, Yusuke Yamashita, (unknown), (unknown), (unknown), (unknown), Hideki Nakakuma, Nobuyoshi Hanaoka, Yasushi Isobe, Kouichi Ohshima, Takashi Sonoki	1
4	PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32) 2015 ·International Journal of Hematology ·(unknown), (unknown), Masayuki Kato, Yuji Nishio, (unknown), (unknown), Satoshi Yokoi, T. Saito, Manabu Matsunawa, Yoshinori Suzuki, Yasushi Isobe, Yasuyuki Inoue, Masatomo Takahashi, Ikuo Miura	2
5	Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type 2012 ·Clinical Cancer Research ·Yoshinori Ito, Hiroshi Kimura, (unknown), Chizuko Hashimoto, Fumihiro Ishida, Koji Izutsu, Noriyasu Fukushima, Yasushi Isobe, Jun Takizawa, Yuichi Hasegawa, Hajime Kobayashi, Seiichi Okamura, Hikaru Kobayashi, Motoko Yamaguchi, Junji Suzumiya, Rie Hyo, Shigeo Nakamura, Keisei Kawa, Kazuo Oshimi, Ritsuro Suzuki	77
6	Aggressive natural killer cell leukemia: Therapeutic potential of l‐asparaginase and allogeneic hematopoietic stem cell transplantation 2012 ·Cancer Science ·Fumihiro Ishida, Young Hyeh Ko, Won Seog Kim, Junji Suzumiya, Yasushi Isobe, Kazuo Oshimi, Shigeo Nakamura, Ritsuro Suzuki	58
7	A monoclonal expansion of Epstein–Barr virus-infected natural killer cells after allogeneic peripheral blood stem cell transplantation 2012 ·Journal of Clinical Virology ·Yasushi Isobe, (unknown), Yoshinori Ito, Hiroshi Kimura, Nobuhiro Tsukada, Koichi Sugimoto, Norio Komatsu	0
8	Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis 2011 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Yoko Tabe, (unknown), (unknown), (unknown), Nanae Aritaka, Yasushi Isobe, Kazuo Oshimi, Norio Komatsu, Takashi Miida, Akimichi Ohsaka	1
9	Suppression of eIF4E Expression by <i>L</i>-Asparaginase 2010 ·Acta Haematologica ·(unknown), Hajime Yasuda, Yasushi Isobe, Makoto Sasaki, (unknown), (unknown), Kazuo Oshimi, Norio Komatsu, Koichi Sugimoto	5
10	Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutatedIGHgene, and indolent clinical behavior 2010 ·Leukemia & lymphoma ·Junichi Tomomatsu, Yasushi Isobe, Kazuo Oshimi, Yoko Tabe, Kiyoshi Ishii, Masaaki Noguchi, T Hirano, Norio Komatsu, Koichi Sugimoto	16
11	Frequent STAT3 activation is associated with Mcl‐1 expression in nasal NK‐cell lymphoma 2009 ·International Journal of Laboratory Hematology ·(unknown), Hajime Yasuda, (unknown), Haruka Imai, Yasushi Isobe, Makoto Sasaki, Yuko Kojima, Kazuo Oshimi, Koichi Sugimoto	19
12	Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate 2009 ·Internal Medicine Journal ·Yasushi Isobe, Koichi Sugimoto, (unknown), Y Hamano, Kazuo Oshimi	25
13	Current and future perspectives on the TARGET system: the registration system for Glivec® established by the JSH 2008 ·International Journal of Hematology ·(unknown), Masahiro Kizaki, Shinichiro Okamoto, Tetsuzo Tauchi, Hideo Tanaka, Mitsune Tanimoto, Koiti Inokuchi, Tohru Murayama, Yoshio Saburi, Masayuki Hino, Mitsuru Tsudo, Taizo Shimomura, Yasushi Isobe	10
14	Expression levels of apoptosis‐related proteins and Ki‐67 in nasal NK / T‐cell lymphoma 2008 ·European Journal Of Haematology ·Hajime Yasuda, Koichi Sugimoto, (unknown), Yasushi Isobe, Makoto Sasaki, Yuko Kojima, Shinji Nakamura, Kazuo Oshimi	19
15	Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1 2007 ·Oncogene ·Koichi Sugimoto, Makoto Sasaki, Yasushi Isobe, (unknown), (unknown), Jun Ando, Kenji Tamayose, Miki Ando, Kazuo Oshimi	21
16	Neural cell adhesion molecule (CD56)‐positive B‐cell lymphoma 2007 ·European Journal Of Haematology ·Yasushi Isobe, Koichi Sugimoto, Kengo Takeuchi, (unknown), (unknown), Takeshi Mori, Kazuo Oshimi	14
17	DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3−CD56+ fractions 2004 ·Leukemia ·Young-Lim Choi, Hideki Makishima, Jun Ohashi, Yumi Yamashita, Ruri Ohki, Koji Koinuma, Jun Ota, Yasushi Isobe, Fumihiro Ishida, Kazuo Oshimi, Hiroyuki Mano	19
18	Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy 2004 ·European Journal Of Haematology ·Koichi Sugimoto, (unknown), Yasushi Isobe, Kenji Tamayose, Masashi Hieda, Kazuo Oshimi	20
19	Detection of chimaeric transcripts of the immunoglobulin heavy chain and BCL6 genes by reverse‐transcriptase polymerase chain reaction in B‐cell non‐Hodgkin's lymphomas 1998 ·British Journal of Haematology ·Norihiko Kawamata, Yuichi Nakamura, Toru Miki, Eriko Sato, Yasushi Isobe, (unknown), Shinsaku Hirosawa, Kazuo Oshimi	12
20	Multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia 1998 ·Annals of Hematology ·(unknown), (unknown), Yasushi Isobe, (unknown), Tomoshige Matsumoto, K Suda, Kazuhiko Funabïki, Yasuhiko Tomino, (unknown), Kazuo Oshimi	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact